Madrigal Pharmaceuticals Reports 2020 Fourth Quarter and Full Year Financial Results and HighlightsFebruary 25, 2021
Madrigal Pharmaceuticals Highlights Presentations at The Liver Meeting Digital ExperienceTM, The American Association for the Study of Liver Diseases Meeting November 13, 2020, Including NASH Expert Insights on the Ongoing Open Label Arm of Resmetirom 52-Week Phase 3 MAESTRO- NAFLD-1 TrialNovember 13, 2020
Madrigal Pharmaceuticals Announces Completion of Enrollment in Phase 3 MAESTRO NAFLD-1 Trial and Reports 2020 Third Quarter Financial Results and HighlightsNovember 5, 2020
Press Release History